Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Dual site phospholamban phosphorylation and its physiological relevance in the heart.

Hagemann D, Xiao RP.

Trends Cardiovasc Med. 2002 Feb;12(2):51-6. Review.

PMID:
11852250
2.

Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes.

Hagemann D, Kuschel M, Kuramochi T, Zhu W, Cheng H, Xiao RP.

J Biol Chem. 2000 Jul 21;275(29):22532-6.

3.
4.

Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.

Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E.

Cardiovasc Res. 2005 Dec 1;68(3):366-75. Epub 2005 Oct 13. Review.

PMID:
16226237
5.

Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways.

Vittone L, Mundiña-Weilenmann C, Said M, Ferrero P, Mattiazzi A.

J Mol Cell Cardiol. 2002 Jan;34(1):39-50.

PMID:
11812163
6.

A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.

Chu G, Lester JW, Young KB, Luo W, Zhai J, Kranias EG.

J Biol Chem. 2000 Dec 8;275(49):38938-43.

8.

Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation.

Frank KF, Bölck B, Erdmann E, Schwinger RH.

Cardiovasc Res. 2003 Jan;57(1):20-7. Review.

PMID:
12504810
9.

Oligomeric interactions between phospholamban molecules regulate Ca-ATPase activity in functionally reconstituted membranes.

Yao Q, Chen LT, Li J, Brungardt K, Squier TC, Bigelow DJ.

Biochemistry. 2001 May 29;40(21):6406-13.

PMID:
11371203
10.

Phosphorylation states of phospholamban.

Colyer J.

Ann N Y Acad Sci. 1998 Sep 16;853:79-91. Review.

PMID:
10603938
11.

Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.

Brixius K, Wollmer A, Bölck B, Mehlhorn U, Schwinger RH.

Pflugers Arch. 2003 Nov;447(2):150-7. Epub 2003 Oct 3.

PMID:
14530977
12.

CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.

Yurukova S, Kilić A, Völker K, Leineweber K, Dybkova N, Maier LS, Brodde OE, Kuhn M.

Cardiovasc Res. 2007 Mar 1;73(4):678-88. Epub 2006 Oct 7.

PMID:
17107670
13.
14.

Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure.

Netticadan T, Temsah RM, Kawabata K, Dhalla NS.

Circ Res. 2000 Mar 17;86(5):596-605.

15.
16.

Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation.

Kuschel M, Karczewski P, Hempel P, Schlegel WP, Krause EG, Bartel S.

Am J Physiol. 1999 May;276(5 Pt 2):H1625-33.

18.
19.

Molecular mechanisms of reduced sarcoplasmic reticulum Ca(2+) uptake in human failing left ventricular myocardium.

Mishra S, Gupta RC, Tiwari N, Sharov VG, Sabbah HN.

J Heart Lung Transplant. 2002 Mar;21(3):366-73.

PMID:
11897526
20.

Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.

Vasanji Z, Dhalla NS, Netticadan T.

Mol Cell Biochem. 2004 Jun;261(1-2):245-9.

PMID:
15362510

Supplemental Content

Support Center